Alkem Laboratories has developed a low-cost sweetener that can be a game changer in the market which houses the most number of diabetes patients in the world.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Alkem-Lab-develops-low-cost-sweetener/articleshow/6471411.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Alkem-Lab-develops-low-cost-sweetener/articleshow/6471411.cmsTue, 31 Aug 2010 21:13:39 GMTAlkem Lab develops low-cost sweetenerAlkem Lab develops low-cost sweetener
Biotechnology firm Biocon Ltd expects revenue growth of 15 per cent over the next two years each, while seeking partnerships with global drugmakers for experimental drugs, its finance chief said.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-sees-15-pc-growth-in-2-yrs/articleshow/6421257.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-sees-15-pc-growth-in-2-yrs/articleshow/6421257.cmsMon, 23 Aug 2010 11:11:56 GMTBiocon sees 15 pc growth in 2 yrsBiocon sees 15 pc growth in 2 yrs
Biocon Ltd expects revenue growth of 15% over the next two years each, while seeking partnerships with global drugmakers.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-sees-15-per-cent-revenue-growth-in-2-years/articleshow/6420962.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-sees-15-per-cent-revenue-growth-in-2-years/articleshow/6420962.cmsMon, 23 Aug 2010 10:12:25 GMTBiocon sees 15 per cent revenue growth in 2 yearsBiocon sees 15 per cent revenue growth in 2 years
Camson Biotechnologies, an agricultural biotechnology firm, plans to set up joint ventures in Singapore, Dubai and Egypt, a top company official said.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Camson-Biotech-plans-to-set-up-JVs-in-Singapore-Dubai-Egypt/articleshow/6383353.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Camson-Biotech-plans-to-set-up-JVs-in-Singapore-Dubai-Egypt/articleshow/6383353.cmsFri, 20 Aug 2010 16:28:06 GMTCamson Biotech plans to set up JVs in Singapore, Dubai, EgyptCamson Biotech plans to set up JVs in Singapore, Dubai, Egypt
The Biotechnology Regulatory Authority bill, scheduled to be introduced in Parliament imminently, will not open the floodgates to genetically modified (GM) food.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biotech-Regulatory-Authority-bill-for-safety-and-efficacy-Ramesh/articleshow/6332220.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biotech-Regulatory-Authority-bill-for-safety-and-efficacy-Ramesh/articleshow/6332220.cmsWed, 18 Aug 2010 15:35:05 GMTBiotech Regulatory Authority bill for safety and efficacy: RameshBiotech Regulatory Authority bill for safety and efficacy: Ramesh
In a breakthrough which may pave way for an effective treatment of inoperable cancers, scientists at Bhabha Atomic Research Centre (BARC) have developed promising radio pharmaceuticals.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/BARC-develops-radionuclides-for-inoperable-cancers-arthritis/articleshow/6329863.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/BARC-develops-radionuclides-for-inoperable-cancers-arthritis/articleshow/6329863.cmsWed, 18 Aug 2010 07:11:20 GMTBARC develops radionuclides for inoperable cancers, arthritisBARC develops radionuclides for inoperable cancers, arthritis
India's bio-tech industry clocked a 17 percent growth with revenues of Rs.137 billion ($3 billion) in the 2009-10 financial year over the previous fiscal, according to a survey.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Indian-biotech-industry-grew-17-percent-in-2009-10-Survey/articleshow/6075713.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Indian-biotech-industry-grew-17-percent-in-2009-10-Survey/articleshow/6075713.cmsMon, 21 Jun 2010 14:18:49 GMTIndian biotech industry grew 17 percent in 2009-10: SurveyIndian biotech industry grew 17 percent in 2009-10: Survey
Companies based in Mumbai and other parts of western India dominate the Indian biotech sector, pushing Bangalore down to second place, a survey by a leading biotech body has shown.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Mumbai-firms-beat-Blore-peers-in-biotech-zone/articleshow/6061063.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Mumbai-firms-beat-Blore-peers-in-biotech-zone/articleshow/6061063.cmsThu, 17 Jun 2010 22:38:48 GMTMumbai firms beat B'lore peers in biotech zoneMumbai firms beat B'lore peers in biotech zone
The Defence Research and Development Organisation (DRDO), which caters primarily to the armed forces, plans to upgrade and custom-make its existing slew of biotech products for civilian use.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/DRDO-to-invest-Rs-300-cr-to-upgrade-biotech-products-for-civilian-use/articleshow/6018219.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/DRDO-to-invest-Rs-300-cr-to-upgrade-biotech-products-for-civilian-use/articleshow/6018219.cmsSun, 06 Jun 2010 19:39:21 GMTDRDO to invest Rs 300 cr to upgrade biotech products for civilian useDRDO to invest Rs 300 cr to upgrade biotech products for civilian use
The global biotechnology industry is moving towards strategic partnerships in a bid to create faster and cost-efficient means of drug discovery.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Global-biotech-firms-seek-partnerships-in-India-for-bigger-gains/articleshow/6018217.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Global-biotech-firms-seek-partnerships-in-India-for-bigger-gains/articleshow/6018217.cmsSun, 06 Jun 2010 19:37:32 GMTGlobal biotech firms seek partnerships in India for bigger gainsGlobal biotech firms seek partnerships in India for bigger gains
Malaysia is keen to work with Indian companies venturing into biotechnology as it has offered attractive incentives and infrastructure to them for expanding their reach in the country.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Malaysia-offers-good-incentives-for-Indian-biotech-companies/articleshow/6007251.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Malaysia-offers-good-incentives-for-Indian-biotech-companies/articleshow/6007251.cmsThu, 03 Jun 2010 09:30:57 GMTMalaysia offers good incentives for Indian biotech companiesMalaysia offers good incentives for Indian biotech companies
India's biotech industry bounced to high growth in fiscal 2009-10 to post revenues of $4 billion, a whopping 52 per cent over the previous fiscal.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Indian-biotech-sector-rebounds-on-global-recovery/articleshow/6003083.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Indian-biotech-sector-rebounds-on-global-recovery/articleshow/6003083.cmsWed, 02 Jun 2010 09:49:03 GMTIndian biotech sector rebounds on global recoveryIndian biotech sector rebounds on global recovery
A day after genome pioneer J Craig Venter announced he had created 'synthetic' life, the scientific world was agog over the merits and demerits of Craig's seemingly dramatic work.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Artificial-life-or-plain-genetic-engineering/articleshow/5960479.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Artificial-life-or-plain-genetic-engineering/articleshow/5960479.cmsFri, 21 May 2010 22:50:59 GMTArtificial life or plain genetic engineering?Artificial life or plain genetic engineering?
US scientists announced a bold step on Friday in the enduring quest to create artificial life.- that they have produced a living cell powered by man-made DNA.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Towards-artificial-life-Cell-powered-by-man-made-DNA/articleshow/5960141.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Towards-artificial-life-Cell-powered-by-man-made-DNA/articleshow/5960141.cmsFri, 21 May 2010 19:02:59 GMTTowards artificial life: Cell powered by man-made DNATowards artificial life: Cell powered by man-made DNA
Indian biotech companies are increasingly looking to make major investments in Malaysia, lured by the south-east Asian country's tax sops, easy market access and better infrastructure.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Malaysia-calling-for-Indian-biotech-cos/articleshow/5955974.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Malaysia-calling-for-Indian-biotech-cos/articleshow/5955974.cmsThu, 20 May 2010 20:46:46 GMTMalaysia calling for Indian biotech cosMalaysia calling for Indian biotech cos
